The Institute for Advanced Chemistry of Catalonia (IQAC-CSIC) seeks a postdoctoral researcher to expandpreclinical validation of a proprietary immunotherapy developed at IQAC, a peptide-drug conjugate called MACTIDE-V. This conjugate reprograms tumor-associated macrophages, unleashing potent immunos